Discover more
than you think

Leveraging BRET-based technologies unleashing the full drug discovery potential

Discover bioSens-All®

About our technologies

Continuously investing in our BRET-based biosensor technology, allowing to get powerful new insights on the functional pharmacology of native and variant transmembrane receptors to develop tailored, safer, and more efficacious therapeutics.

Specifically, we use a unique and proprietary set of biosensors, without tagging the receptors, to better understand the proximal signal transduction pathways of G protein coupled receptors (GPCRs), and Receptor Tyrosine Kinases (RTKs). We continue to expand the application of the technology to other transmembrane receptors such as Immune Checkpoint Receptors.